Atlas Trials

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

Clinical trial NCT01309633 · COMPLETED

Trial details

NCT number
NCT01309633
Sponsor
National University Hospital, Singapore
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2011-09-02
Primary completion
2019-03-11
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.